new england journal of medicine semaglutide Happy to share the publication the STEP 9 study in the of (NEJM): Once-Weekly in Persons with Obesity and Knee Osteoarthritis. The study showed that among… Patients with type 2 #diabetes

and 2.1% vs

If you experience severe dizziness, irregular heartbeat, or persistent swelling, seek medical attention immediately

Tapering Considerations: Gradually reduce GLP-1 dosing while increasing fiber and protein intake Begin nutraceutical support (e.g., berberine, chromium) 24 weeks prior to taper Monitor lean mass and glycemic variability Support appetite signaling with mindful eating and circadian regulation Address gut motility and emotional eating patterns with botanical support Clinical Example: A Case in Practice A 52-year-old female on semaglutide for 6 months presented with nausea, fatigue, and concern about lean mass loss

Most patients notice reduced appetite within the first few days of their initial injection, often describing decreased food cravings, earlier satiety during meals, and reduced interest in snacking between meals

The tirzepatide and oral contraceptive data The most striking evidence comes from tirzepatide clinical trials

With over 500,000 users in the UK alone and 12% of Americans reportedly trying GLP-1 drugs, the timing doesnt seem coincidental